Who Benefits? An Assessment of Resident Benefits at Top 50 Academic Institutions
Harold J. Leraas(Duke Medical Center), Elisabeth T. Tracy(University of North Carolina at Chapel Hill), John Migaly(Johns Hopkins University), Ahmad Mourad, Doreen Chang(Duke Medical Center), Lillian Kang(Duke University), Marcelo Cerullo(Duke University Hospital), Colin A. Martz(Duke University), Kristen E. Rhodin(Duke University)
Cited by 2
Related Papers
Systematic identification of signaling pathways with potential to confer anticancer drug resistance
|Science Signaling|2014|199
Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia
|Scientific Reports|2016|180
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
|The Lancet Respiratory Medicine|2022|127
Pediatric injury patterns by year of age
|Journal of Pediatric Surgery|2013|106
Biomarkers for Wilms Tumor: A Systematic Review
|The Journal of Urology|2016|95